The next big thing in pharma might not be something you like
Hospitals competing on pharma’s turf by supplying their own generics signals a tectonic shift, and don’t expect it to go away anytime soon.
Hospitals competing on pharma’s turf by supplying their own generics signals a tectonic shift, and don’t expect it to go away anytime soon.
This issue includes the 2020 MM&M/Elevate Healthcare Marketers Trend report and features on online health communities and behavioral marketing campaigns.
There are many challenges that come with identifying and deploying insights that resonate with patients, but the two behavioral marketing campaigns examined successfully thread the needle.
Pharma IMPACT prepares for a dual-track approach on March 18 and 19 in New York City.
Despite their increasing scale and intensified interest from medical marketers, digital health communities are still misunderstood. We thought it was time to clear up six of the biggest misconceptions.
We tease out the overarching trends in four areas: budget, audience, tactics and the forces impacting industry.
With budgets up yet again, industry marketers are drowning out the political noise and pouncing on the opportunities that present themselves.
Industry veteran Frank X. Powers, Elevate Healthcare’s cofounder and managing partner, has witnessed how pharmaceutical, device and diagnostics companies have contended with the ebb and flow of marketing budgets over the years.
A recent trip to the West Coast for a health conference showed the importance of personal experience in health marketing, with or without handshakes.
MannKind has rebranded for the first time in 20 years as CEO Michael Castagna looks to lead the company’s turnaround.